Caribou Biosciences (CRBU) Change in Account Payables (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Change in Account Payables came in at -$2.2 million in Q1 2026, down 258.12% year-on-year from $1.4 million in Q1 2025, and down 215.69% on a QoQ basis from $1.9 million in Q4 2025.
Caribou Biosciences (CRBU) Change in Account Payables (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Change in Account Payables data on file, last reported at -$2.2 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 258.12% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$370000.0, a 77.84% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 1019.21% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.2 million, down from $1.9 million in the prior quarter.
- Over the last five years, Change in Account Payables for CRBU reached as high as $2.7 million in Q1 2024 and fell as low as -$2.4 million in Q2 2024.
- Historically, Change in Account Payables has averaged -$13058.8 across 5 years, with a median of -$153000.0 in 2022.
- Across the five-year window, Change in Account Payables sank 5275.68% in 2022 and soared 937.99% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$153000.0 in 2022, then jumped by 577.12% to $730000.0 in 2023, then plunged by 131.37% to -$229000.0 in 2024, then surged by 937.99% to $1.9 million in 2025, then slumped by 215.69% to -$2.2 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$2.2 million in Q1 2026, $1.9 million in Q4 2025, and $561000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 Mn |
| Mar 31, 2026 | -2.22 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 561,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -630,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -229,000.00 |
| Dec 31, 2024 | -229,000.00 |
| Sep 30, 2024 | -477,000.00 |
| Sep 30, 2024 | -477,000.00 |
| Jun 30, 2024 | -2.37 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 730,000.00 |
| Dec 31, 2023 | 730,000.00 |